Details for New Drug Application (NDA): 019399
✉ Email this page to a colleague
NDA 019399 describes TPN ELECTROLYTES IN PLASTIC CONTAINER, which is a drug marketed by Abbott and Hospira and is included in two NDAs. It is available from one supplier. Additional details are available on the TPN ELECTROLYTES IN PLASTIC CONTAINER profile page.
The generic ingredient in TPN ELECTROLYTES IN PLASTIC CONTAINER is calcium chloride; magnesium chloride; potassium chloride; sodium acetate; sodium chloride. There are two hundred and eighty-two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the calcium chloride; magnesium chloride; potassium chloride; sodium acetate; sodium chloride profile page.
The generic ingredient in TPN ELECTROLYTES IN PLASTIC CONTAINER is calcium chloride; magnesium chloride; potassium chloride; sodium acetate; sodium chloride. There are two hundred and eighty-two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the calcium chloride; magnesium chloride; potassium chloride; sodium acetate; sodium chloride profile page.
Summary for 019399
| Tradename: | TPN ELECTROLYTES IN PLASTIC CONTAINER |
| Applicant: | Abbott |
| Ingredient: | calcium chloride; magnesium chloride; potassium chloride; sodium acetate; sodium chloride |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 16.5MG/ML;25.4MG/ML;74.6MG/ML;121MG/ML;16.1MG/ML | ||||
| Approval Date: | Jun 16, 1986 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
